# NeuroRx, Inc.: Form D filings

NeuroRx, Inc., a pharmaceuticals company in Wilmington, DE, filed 2 Form D notices with the SEC in 2016. The latest, on November 23, 2016, reports $2.2 million sold of a $2.2 million offering to 16 investors.

Find out what NeuroRx, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20NeuroRx%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=NeuroRx%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fneurorx-inc-1679768)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20NeuroRx%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=NeuroRx%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fneurorx-inc-1679768)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Delaware](https://specstream.ai/data/form-d/state/delaware): 1,342 rows, by operating companies, filed since November 1, 2024, $67.10, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/delaware
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 1201 Orange Street, Suite 600, One Commerce Center, Wilmington, DE, 19801
- Phone: (212) 643-0417
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2015
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1679768

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Nov 23, 2016 | New notice | $2,159,687 | $2,159,687 | $0 | 16 | Nov 10, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1679768/000167976816000003/0001679768-16-000003-index.htm) |
| Nov 23, 2016 | New notice | $5,541,991 | $4,541,991 | $1,000,000 | 11 | Nov 10, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1679768/000167976816000002/0001679768-16-000002-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Jonathan Javitt | Executive Officer, Director |  |
| James Lawrence | Director |  |
| Sherry Glied | Director |  |
| Chaim Hurvitz | Director |  |
| Daniel Javitt | Director |  |

[Every Form D from the week of Nov 21, 2016](https://specstream.ai/data/form-d/week/2016-11-21) · [All recent filings in Delaware](https://specstream.ai/data/form-d/state/delaware) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what NeuroRx, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).